Transcranial Magnetic Stimulation

Since the first transcranial magnetic stimulation (TMS) system was cleared by the U.S. Food and Drug Administration in 2008 to treat major depressive disorder in adult patients, the field of TMS has experienced tremendous growth. Despite the growing availability of this option-and expanding insurance coverage-many practitioners remain unsure about how to best apply TMS.

That is what makes this second edition of Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice such a critical resource. Updated to reflect the latest research and evolving clinical practices, this volume addresses practical aspects that include patient selection and practice management and delves into the clinical application of TMS in cases of treatment-resistant depression and other mood disorders.


                Key updates in this guide include   


                * New chapters on the use of TMS for obsessive-compulsive disorder and important practice management tips for TMS clinicians.

• Expanded content on integrating pharmacotherapy and psychotherapy with TMS, reflecting deeper integration into treatment strategies.
• New guidance on using TMS in the treatment of major depressive disorder.
• The incorporation of recent and future innovations, including theta burst stimulation, accelerated TMS, and frequency-personalized TMS.